Plain-English translation of NCT07544823 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to find reliable blood tests and other biological markers that could help doctors diagnose osteoarthritis—a common wear-and-tear joint disease—much earlier than they can today. Researchers will collect information and samples from about 300 people with joint pain to see if certain markers in the blood can predict or confirm early-stage arthritis before serious damage occurs.
Osteoarthritis affects millions of people and causes pain, disability, and reduced quality of life—especially in older adults. Right now, doctors often diagnose it only after significant joint damage has already happened. This study aims to develop earlier detection methods so people can get treatment sooner, potentially preventing or slowing the disease's progression.
You likely qualify if…
You likely don't qualify if…
You would visit the research hospital for evaluations that include physical exams, blood tests, and imaging scans like X-rays or MRI to look at your joints. The study will compare people with early-stage arthritis to those with similar symptoms from other causes, helping researchers understand which blood markers are most useful for early diagnosis. You would need to be willing to return for follow-up visits to complete all required tests.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China